Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 698
Selected: 0
NCT IDTitle
NCT03850509Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation
NCT06937593A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954
NCT06740526Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
NCT01451164A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia
NCT00712686Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia
NCT00261443A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
NCT04233346The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation
NCT02196805A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers
NCT01895322Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
NCT00885079Confirmatory Study of OPC-12759 Ophthalmic Suspension
NCT02012959Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
NCT01955161Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
NCT00101569Aripiprazole Oral Acceptability Trial
NCT04038957A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging
NCT06971731A Study of JNT-517 in Participants With Phenylketonuria (PKU)
NCT01739829Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus
NCT01076322A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients
NCT01859923A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)
NCT00132886Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure
NCT00237913Schizophrenia Trial of Aripiprazole
NCT02108288Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers
NCT01438060Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type
NCT05279313A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.
NCT00046384Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder
NCT00234078Dose-response Study of OPC-12759 Ophthalmic Suspension
NCT00337571Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
NCT07713758A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function
NCT01628926A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients
NCT07314333A Trial to Assess How Centanafadine Interacts With Stimulants in the Body
NCT03605849A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
NCT04770285Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder
NCT01727700Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT03854409A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder
NCT05048069Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.
NCT02250170Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor
NCT03418675Brexpiprazole in Borderline Personality Disorder
NCT00823875Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject
NCT04782258A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
NCT02382276A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence
NCT00048776Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
NCT00504426Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis
NCT00876343Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
NCT03197714Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia
NCT02105285Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
NCT00549978Safety and Pharmacokinetics of Probucol and Cilostazol
NCT00841568A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]
NCT01710709Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
NCT03238326Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia
NCT02473393A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis
NCT01074294Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder